Tanaka M, Yoshida S
J Biochem. 1980 Mar;87(3):911-8. doi: 10.1093/oxfordjournals.jbchem.a132821.
The anthracycline antibiotics, daunomycin and adriamycin, strongly inhibited the reactions of both DNA polymerase alpha and beta from calf thymus by competing with the template primers, i.e., activated DNA or initiated deoxyhomopolymers. DNA polymerase alpha was more sensitive to both drugs than DNA polymerase beta with all the template-primers tested. With poly(dT).oligo(dA), the activity of the alpha-enzyme was extremely sensitive to these drugs (Ki, 0.9 microM for daunomycin), while that of the beta-enzyme was relatively resistant (Ki, 25 microM for daunomycin). Much stronger inhibition was produced by preincubating these drugs with the enzymes than with the template-primers, and the inhibition of DNA polymerase activity was reversed by the addition of excess template-primers. These results indicate that the inhibition was produced mainly by direct interaction of the drugs with DNA polymerases rather than by impairing the template activity of DNA due to intercalation of the drugs. Although adriamycin inhibited DNA polymerases alpha and beta to slightly higher extents than daunomycin, the modes of inhibition by these two drugs were quite similar.
蒽环类抗生素柔红霉素和阿霉素通过与模板引物(即活化的DNA或起始的脱氧同聚物)竞争,强烈抑制小牛胸腺DNA聚合酶α和β的反应。在所有测试的模板引物中,DNA聚合酶α比DNA聚合酶β对这两种药物更敏感。对于聚(dT)·寡聚(dA),α酶的活性对这些药物极其敏感(柔红霉素的Ki为0.9微摩尔),而β酶的活性相对耐药(柔红霉素的Ki为25微摩尔)。这些药物与酶预孵育产生的抑制作用比与模板引物预孵育产生的抑制作用更强,并且通过添加过量的模板引物可逆转DNA聚合酶活性的抑制。这些结果表明,抑制作用主要是由药物与DNA聚合酶的直接相互作用产生的,而不是由于药物嵌入导致DNA模板活性受损。尽管阿霉素对DNA聚合酶α和β的抑制程度略高于柔红霉素,但这两种药物的抑制模式非常相似。